The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The Institute of Laboratory Medicine and Pathobiochemistry, is known for the pioneering research on the molecular understanding of the pathogenesis and developing novel therapeutic strategies for different chronic airway inflammatory diseases. It offers cutting edge educational platform for undertaking translational research training for young researchers and clinicians at different academic levels and makes invaluable contribution to further generation researchers in the field of respiratory research. Importantly, the institute tirelessly working on different experimental and computational approaches to understand the role of early life microbiome and microbial metabolites in developing chronic allergic airway inflammatory diseases (e.g., asthma) in later life.
Asthma/Biomarkers/Cell biology/Epigenetics/Immunology/Ventilation
Global fellowships (return phase only)\European fellowships
The research activities are focusing on gene environment and reaction in chronic inflammation with special focus on allergic inflammation. This includes animal models, in-vitro studies, translational research and clinical studies.
The Institute of Laboratory Medicine is a fully equipped laboratory to perform cellular, molecular, biochemical research with state of the art technologies.
The laboratory is set up in order to perform animal studies as well as human in-vitro studies. The state of the art diagnostic laboratory is also available for clinical and translational research activities in offering more than 800 analytes for analysis.
The institute is host of the clinical mass spectrometry core facility of the medical faculty.
We have received funding for numerous research projects for understanding and addressing the respiratory problems by German Research Foundation (DFG) and national funding agencies. Also, collaborations with other European research groups working on respiratory diseases are ongoing for many years which lead many high impact publications in past few years.
Due to the translational research programme, the institute has had long lasting collaborations with SME´s and the pharmaceutical industry – cooperations related to novel therapeutic and diagnostic strategies in chronic inflammation. Furthermore, HR Co-founded Sterna biologicals, a start-up company pioneering the use of antisense molecules, based on the DNAzyme -technology. In addition HR served as Co-founder of Secarna pharmaceuticals, which is a sister-company, developing therapeutic antisense-molecules in other fields of medicine. Beyond allergy and asthma.
The institute is actively involved in giving training to national/international Masters, MD, and Ph.D. students. The institute provides substantial assistance especially to early career researchers to facilitate their progression to research independence. All the researchers are encouraged to attend and present at national and international scientific meetings. Further, we also provide career planning support to researchers at various stages.
Yes
